Sanofi

Sanofi Book Value per Share

The Book Value per Share of Sanofi (SAN.PA) as of Nov 2, 2026 is 58.49 EUR. In the previous year, Book Value per Share was 63.51 EUR — a change of -7.91% (lower).

Book Value per Share

58.49EUR

YoY

-7.91%

Last updated:

Book Value per Share of Sanofi is 2025 58.49 EUR. Book Value per Share of Sanofi was 2024 63.51 EUR. It decreases by -7.91% lower compared to the previous year.

The Sanofi Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
48.24 EUR
Jan 1, 2019
48.29 EUR
Jan 1, 2020
51.62 EUR
Jan 1, 2021
56.28 EUR
Jan 1, 2022
59.93 EUR
Jan 1, 2023
60.67 EUR
Jan 1, 2024
63.51 EUR
Jan 1, 2025
58.49 EUR
The Sanofi Book Value per Share history
YEARBook Value per ShareYoY
58.49EUR-7.91%
63.51EUR+4.68%
60.67EUR+1.22%
59.93EUR+6.50%
56.28EUR+9.02%
51.62EUR+6.90%
48.29EUR+0.10%
48.24EUR+1.39%
47.58EUR+0.90%
47.16EUR-0.85%
47.57EUR+3.44%
45.98EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sanofi Stock analysis

What does Sanofi do? Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanofi stock

Book Value per Share of Sanofi is 58.49 EUR in 2025.

Book Value per Share of Sanofi changed from 63.51 EUR to 58.49 EUR, representing a -7.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Sanofi since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sanofi

All Key Metrics — Sanofi